Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;32(4):342-347.
doi: 10.4103/ijn.ijn_345_21. Epub 2022 May 7.

Renal Lymphoma Diagnosed on Kidney Biopsy Presenting as Acute Kidney Injury

Affiliations

Renal Lymphoma Diagnosed on Kidney Biopsy Presenting as Acute Kidney Injury

Swapna Nuguri et al. Indian J Nephrol. 2022 Jul-Aug.

Abstract

Introduction: Renal manifestations associated with hematolymphoid malignancies are known. Primary or secondary involvement of the kidney by lymphomatous infiltration has various clinical presentations. Acute kidney injury is not an uncommon finding in relation to lymphomatous interstitial infiltration proven on kidney biopsy. However, diagnosing it solely on renal biopsy remains a challenge and needs expertise and aid of immunohistochemistry as the prognosis is dismal.

Methods: This is a retrospective study of kidney biopsy-proven cases of renal lymphoma presenting with acute kidney injury.

Results: The study included 12 patients with ages ranging from 4 to 50 years who presented with serum creatinine ranging 2.1-9.6 mg%. Renal biopsy findings showed interstitial lymphomatous infiltrate. Two cases were diagnosed as primary lymphoma and the other 10 as secondary lymphomas. Among the 12 cases, nine were B-cell non-Hodgkin lymphoma, of which diffuse large B-cell lymphoma was diagnosed in six (50%), low-grade B-cell type in two (16.6%), chronic lymphocytic leukemia in one (8.3%), and three were T-cell-type. Two were acute T-cell lymphoblastic lymphoma and one other was a high-grade T-cell lymphoma. Four patients succumbed. The other four patients are alive; one is on chemotherapy, while two of them are on hemodialysis.

Conclusion: Acute kidney injury as a presenting feature with lymphomatous infiltration of renal parenchyma is not uncommon. The patchy involvement makes it challenging on kidney biopsy with definitive diagnosis being made with the help of immunohistochemistry. Appropriate multidisciplinary involvement improves patient outcome.

Keywords: Acute kidney injury; lymphomatous infiltrate; renal lymphoma.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Typing of lymphomatous interstitial infiltrate
Figure 2
Figure 2
Kidney biopsy showing interstitial involvement by small to medium-sized atypical lymphoid cells. H and E, 1 is ×10, 2 and 3 is ×200, 4 is ×400
Figure 3
Figure 3
IHC on kidney biopsy shows interstitial lymphomatous infiltrate is CD 20 positive in 1, CD3 positive in 2, TDT positive in 3, occasional CD20 positive in 4, CD3 positive in reactive lymphoid cells, and negative in atypical cells in 5. ×400

Similar articles

Cited by

References

    1. Morel A, Meuleman MS, Moktefi A, Audard V. Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits. Diagnostics. 2021;11:1–16. - PMC - PubMed
    1. Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014;21:27–35. - PubMed
    1. Richmond J, Sherman RS, Diamond HD, Craver LF. Renal lesions associated with malignant lymphomas. Am J Med. 1962;32:184–207. - PubMed
    1. Kwakernaak AJ, Herzenberg MD, Roelofs JJ, van Noesel CJ, van Oers MH, van Tellingen A. Precursor T-lymphoblastic lymphoma presenting as primary renal lymphoma with acute renal failure. NDT Plus. 2011;4:289–91. - PMC - PubMed
    1. Kamińska D, Krajewska M, Mazanowska O, Poznański P, Boratyńska M, Klinger M. Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature. Cent Eur J Immunol. 2020;45((4)):498–06. - PMC - PubMed